SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-021421
Filing Date
2021-04-28
Accepted
2021-04-28 16:48:40
Documents
11
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A aveo-def14a_20210609.htm DEF 14A 1839008
2 GRAPHIC gy03ypzafwwa000002.jpg GRAPHIC 2922
3 GRAPHIC gy03ypzafwwa000006.jpg GRAPHIC 7770
4 GRAPHIC gy03ypzafwwa000007.jpg GRAPHIC 1867
5 GRAPHIC gy03ypzafwwa000001.jpg GRAPHIC 9024
6 GRAPHIC gy03ypzafwwa000008.jpg GRAPHIC 1817
7 GRAPHIC gy03ypzafwwa000004.jpg GRAPHIC 7528
8 GRAPHIC gy03ypzafwwa000005.jpg GRAPHIC 8258
9 GRAPHIC gy03ypzafwwa000009.jpg GRAPHIC 96227
10 GRAPHIC gy03ypzafwwa000003.jpg GRAPHIC 6559
11 GRAPHIC gy03ypzafwwa000010.jpg GRAPHIC 74788
  Complete submission text file 0001564590-21-021421.txt   2139373
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34655 | Film No.: 21865018
SIC: 2834 Pharmaceutical Preparations